ACQUIRED HEMOPHILIA A

被引：20

作者：

Franchini, Massimo ^{[1
]}

Lippi, Giuseppe ^{[2
]}

机构：

[1] Univ Hosp Parma, Dept Pathol & Lab Med, Immunohematol & Transfus Ctr, Parma, Italy

[2] Univ Hosp Parma, Clin Chem Lab, Dept Pathol & Lab Med, Parma, Italy

来源：

ADVANCES IN CLINICAL CHEMISTRY, VOL 54 | 2011年 / 54卷

关键词：

FACTOR-VIII; ANTIBODIES; RITUXIMAB; INACTIVATION; INHIBITORS; PROGNOSIS; DIAGNOSIS; KINETICS; BINDING; IGG;

D O I：

10.1016/B978-0-12-387025-4.00003-0

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Acquired hemophilia A is a rare but often life-threatening hemorrhagic disorder characterized by an autoantibody directed against coagulation factor VIII. Fifty per cent of cases are idiopathic whereas the remaining 50% are associated with pregnancy, autoimmune conditions, malignancies and drugs. In this review the actual knowledge on diagnostic and therapeutic aspects of this disease will be summarized.

引用

页码：71 / 80

页数：10

共 50 条

[31] Cautions and caveats to the treatment of acquired hemophilia A
Huth-Kuehne, Angela
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (08): : 1181 - 1182
[32] Treatment of acquired hemophilia A
Collins, P. W.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (05) : 893 - 900
[33] Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
Knoebl, P.
Marco, P.
Baudo, F.
Collins, P.
Huth-Kuhne, A.
Nemes, L.
Pellegrini, F.
Tengborn, L.
Levesque, H.
Aspoek, G.
Heistinger, M.
Knobl, P.
Makipernaa, A.
Andre, H.
Aouba, A.
Bellucci, Sylvia
Beurrier, P.
Borg, J. Y.
Darnige, L.
Devignes, J.
D'Oiron, R.
Gautier, P.
Gay, V.
Girault, S.
Gruel, Y.
Guerin, V.
Hezard, N.
Khellaf, M.
Koenig, M.
Lifermann, F.
Marlu, R.
Ninet, Jacques
Peynet, J.
Quemeneur, T.
Rothschild, C.
Schleinitz, N.
Sigaud, M.
Trouillier, S.
Voisin, S.
Giebl, A.
Holstein, K.
Loreth, R. M.
Steigerwald, U.
Tiede, A.
Theodossiades, G.
Radvanyi, G.
Schlammadinger, A.
Barillari, G.
Pasca, S.
Baudo, F.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (04) : 622 - 631
[34] Update in acquired hemophilia A
Geffray, L.
REVUE DE MEDECINE INTERNE, 2010, 31 (05): : I - IV
[35] Advances in Acquired Hemophilia A
Poston, Jacqueline N.
Kruse-Jarres, Rebecca
TRANSFUSION MEDICINE REVIEWS, 2022, 36 (04) : 215 - 219
[36] Acquired Inhibitors of Coagulation Factors: Part I-Acquired Hemophilia A
Coppola, Antonio
Favaloro, Emmanuel J.
Tufano, Antonella
Di Minno, Matteo Nicola Dario
Cerbone, Anna Maria
Franchini, Massimo
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (05) : 433 - 446
[37] TREATMENT OF ACQUIRED HEMOPHILIA
Cremades Antonio, Quirante
Cardona Lourdes, Pasto
Palmer Elena, Rossello
Masanes Ramon, Jodar
ATENCION FARMACEUTICA, 2009, 11 (04): : 240 - 244
[38] Immunotherapy of acquired hemophilia A
Tiede, Andreas
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 19 - 23
[39] Acquired Hemophilia A: Three Cases and Review of the Literature
Sakalli, H. El Bayed
Matrane, W.
El Hamzaoui, Z.
Oukkache, B.
CLINICAL LABORATORY, 2019, 65 (09) : 1745 - 1750
[40] Acquired hemophilia A: an underdiagnosed, severe bleeding disorder
Zdziarska, Joanna
Musial, Jacek
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2014, 124 (04): : 200 - 206

← 1 2 3 4 5 →